For blood-borne cancer patients, such as those with leukemia, lymphoma and multiple myeloma, and their treating oncologists, the bone marrow biopsy is a critical, but often painful procedure for diagnosis and treatment monitoring. In addition, when performed manually, the procedure is often physically taxing on clinical staff who must obtain a sample of adequate size and quality. Ultimately, the diagnosis you receive from pathology is directly related to the integrity of this sample.
That’s why the Arrow® OnControl® Bone Marrow Biopsy System has become the preferred method of obtaining bone marrow samples at major cancer centers. With the Arrow® OnControl® Powered Bone Access Systems, you can be confident in developing treatment plans based on the diagnosis you receive.
Bone marrow biopsies are widely regarded as being one of the more painful procedures experienced by patients. The resulting high level of anxiety, coupled with the common disappointment of inconclusive sample results make many patients apprehensive about scheduling follow-up procedures. It’s these follow-up procedures that can make or break effective treatment monitoring for patients with leukemia, lymphoma, multiple myeloma and other blood-borne cancers. The Arrow® OnControl® Powered Bone Marrow Biopsy System helps alleviate that patient apprehension by providing results faster 1, and with less pain than the manual alternative3.